17 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... #Neuro #Erenumab ... #Migraine #CGRP
Differential diagnosis of seizures #Diagnosis #EM #Neuro #Seizure #Epileptic #NonEpileptic #Differential #Algorithm #Ddxof
Differential diagnosis ... seizures #Diagnosis #EM ... #Neuro #Seizure ... #NonEpileptic #Differential
Causes of Syncope #Diagnosis #EM #IM #Neuro #Syncope #Differential #Algorithm #Ddxof
Syncope #Diagnosis #EM ... #IM #Neuro #Syncope ... #Differential #
Evaluation of Headache #Diagnosis #Management #EM #Neuro #Headache #Differential #Evaluation #Algorithm #Ddxof
Diagnosis #Management #EM ... #Neuro #Headache ... #Differential #
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
Differential Diagnosis of Syncope
First, is it syncope? History is very important for distinguishing syncope from other
Differential Diagnosis ... #Diagnosis #EM # ... Neuro #IM #Sycope ... #Causes #Differential
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
Generalized Weakness - Differential Diagnosis Framework
"l feel weak":
 • Infectious: Influenza, EBV, PNA, Bacteremia, Sepsis
 •
Generalized Weakness - Differential ... Infectious: Influenza, EBV ... , Infection • Neuro ... Generalized #Weakness #Differential
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
CNS Ring-Enhancing Lesions - Immunocompromised vs Immunocompetent
Multiple Ring-Enhancing Lesions:
 • Toxoplasmosis (CD4 < 100)
 • Other
granulomatosis: • EBV-associated ... Sarcoidosis • Neuro ... Lesions #Brain #differential